SIP 1 | Air Travel and Pregnancy |
SIP 2 | Umbilical Cord Blood Banking |
SIP 6 | Alternatives to HRT for the Management of Symptoms of The Menopause |
SIP 7 | Progress in Cervical Screening in the UK |
SIP 12 | Targeted Therapies for the Management of Ovarian Cancer |
SIP 14 | Clamping of the Umbilical Cord and Placental Transfusion |
SIP 15 | Non-invasive Prenatal Testing for Chromosomal Abnormality using Maternal Plasma DNA |
SIP 21 | Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease |
SIP 22 | Multiple Pregnancy After ART |
SIP 25 | Ovarian Cancer, Optimum Surgery in Advanced-stage |
SIP 34 | Induction of Labour at Term in Older Mothers |
SIP 37 | Chemical Exposures During Pregnancy |
SIP 38 | Stem Cell Therapies in Obstetrics and Gynaecology |
SIP 40 | Sex Steroid Treatment for Pubertal Induction and Replacement in the adolescent Girl |
SIP 45 | Ascites in Ovarian Cancer Patients, Management of |
SIP 46 | Chronic Pelvic Pain Relief, Therapies Targeting the Nervous System for |
SIP 49 | Ultrasound from Conception to 10+0 Weeks of Gestation |
SIP 50 | Developing New Pharmaceutical Treatments for Obstetric Conditions |
SIP 52 | Management of Female Malignant Ovarian Germ Cell Tumours |
SIP 53 | The Role of Natural Killer Cells in Human Fertility |
SIP 55 | The Effect of Surgery for Endometriomas on Fertility |
SIP 56 | Congenital Cytomegalovirus Infection: Update on Treatment |
SIP 57 | Epigenetics and Reproductive Medicine |
SIP 58 | Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes |
SIP 59 | Antenatal and Postnatal Analgesia |
SIP 60 | The Combined Use of USG and Fetal MRI for Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects |
SIP 61 | Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) |
SIP 62 | Reproductive Implications and Management of Congenital Uterine Anomalies |
SIP 63 | Elective Egg Freezing for Non-Medical Reasons |
SIP 64 | Clinical Utility of Prenatal Exam Sequencing in Evaluation of Fetus with Congenital Anomalies |
SIP 65 | Uterine Transplantation |
SIP 66 | Risk-Reducing Salpingo-oophorectomy & Use of HRT below the Age of Natural Menopause |
SIP 67 | Understanding the relationship between social determinants of health and maternal mortality |
SIP 68 | Evaluating misoprostol and mechanical methods for induction of labour |
SIP 69 | The use of Biomarkers to Stratify Surgical Care in Women with Ovarian Cancer |
SIP 70 | Subclinical hypothyroidism and antithyroid autoantibodies in women with subfertility or recurrent pregnancy loss |
SIP 71 | Robotic surgery in gynaecology |
SIP 72 | Laser treatment for genitourinary syndrome of menopause |
SIP 73 | Management of Impacted Fetal Head at Caesarean Birth |
SIP 74 | Use of Expanded Carrier Screening in Reproductive Medicine |
SIP 75 | Use of Novel Therapies in the Management of Haemolytic Disease of the Fetus and Newborn (HDFN) |
SIP 76 | Care of Women With Preterm Prelabour Rupture of the Membranes Prior to 24 +0 Weeks of Gestation |
SIP 77 | Artificial Intelligence in Gynae Oncology |
No comments:
Post a Comment